tradingkey.logo

Inmode Ltd

INMD
View Detailed Chart
15.080USD
+0.260+1.75%
Close 02/06, 16:00ETQuotes delayed by 15 min
953.19MMarket Cap
7.15P/E TTM

Inmode Ltd

15.080
+0.260+1.75%
Intraday
1m
30m
1h
D
W
M
D

Today

+1.75%

5 Days

-4.01%

1 Month

-3.02%

6 Months

+7.87%

Year to Date

+2.65%

1 Year

-17.37%

View Detailed Chart

TradingKey Stock Score of Inmode Ltd

Currency: USD Updated: 2026-02-06

Key Insights

Inmode Ltd's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 70 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 16.60.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Inmode Ltd's Score

Industry at a Glance

Industry Ranking
70 / 205
Overall Ranking
185 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Inmode Ltd Highlights

StrengthsRisks
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Undervalued
The company’s latest PE is 7.15, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 37.33M shares, decreasing 31.16% quarter-over-quarter.
Held by Catherine Wood
Star Investor Catherine Wood holds 137.60K shares of this stock.

Analyst Rating

Based on 8 analysts
Hold
Current Rating
16.600
Target Price
+12.01%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Inmode Ltd News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Inmode Ltd Info

Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Ticker SymbolINMD
CompanyInmode Ltd
CEOMizrahy (Moshe)
Websitehttps://inmodemd.com/
KeyAI